首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Osteoporosis and sarcopenia

缩写:

ISSN:2405-5255

e-ISSN:2405-5263

IF/分区:2.8/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引310
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Ryoma Asahi,Satoshi Yuguchi,Tomohiko Kamo et al. Ryoma Asahi et al.
Objectives: Height loss is associated with vertebral fracture risk and osteoporosis. We assumed that height loss may indicate the risk of falls because the presence of osteoporosis is significantly associated with sarcope...
Manju Chandran,Yun Ann Chin,Kuan Swen Choo et al. Manju Chandran et al.
Objectives: The accuracy of FRAX® as a screening tool to identify osteoporosis and how it compares with tools such as Osteoporosis Self-Assessment Tool for Asians (OSTA), in Southeast Asian women has so far been unexplor...
Md Azharuddin,Mohammad Adil,Rashid Ali Khan et al. Md Azharuddin et al.
This paper systematically and critically reviewed all published economic evaluations of drugs for the treatment of postmenopausal osteoporosis. A systematic search was conducted using relevant databases for economic evaluations to include a...
Taiju Miyagami,Hirohide Yokokawa,Kazutoshi Fujibayashi et al. Taiju Miyagami et al.
Objectives: To investigate the correlation between imbalance of muscle mass to body weight and lifestyle-related diseases using bioelectrical impedance analysis (BIA) among Japanese population. ...
Luis Möckel,Matthias Bartneck,Christina Möckel Luis Möckel
Objectives: Falls are the well-known risk factor for osteoporotic fractures and some medications can increase the risk of falls. Therefore, the aim of our study is to evaluate the effect of romosozumab on risk of falls in...
Hiroaki Okamoto,Nayumi Shibazaki,Takeshi Yoshimura et al. Hiroaki Okamoto et al.
Objectives: On July 20, 2012, the European Medicines Agency (EMA) provided a recommendation that limits the long-term use of calcitonin. Based on this recommendation, we investigate the presence or absence of a cancer dia...
Genichiro Katahira,Kotaro Akiba,Junichi Takada et al. Genichiro Katahira et al.
Objectives: Once-weekly teriparatide (W-TPTD) is an effective drug for patients with osteoporosis; however, some patients discontinue W-TPTD owing to its adverse drug reactions (ADRs). Sequential treatment with W-TPTD and...